World Investment Advisors acquired a new position in shares of Genpact Limited (NYSE:G - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,891 shares of the business services provider's stock, valued at approximately $448,000.
Several other large investors also recently modified their holdings of G. Atlas Capital Advisors Inc. grew its holdings in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the period. Stifel Financial Corp lifted its stake in shares of Genpact by 1.0% in the fourth quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock valued at $1,324,000 after buying an additional 291 shares in the last quarter. Fifth Third Bancorp lifted its stake in shares of Genpact by 9.5% in the first quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock valued at $174,000 after buying an additional 299 shares in the last quarter. KBC Group NV lifted its stake in shares of Genpact by 4.7% in the first quarter. KBC Group NV now owns 7,266 shares of the business services provider's stock valued at $366,000 after buying an additional 324 shares in the last quarter. Finally, OneAscent Wealth Management LLC lifted its stake in shares of Genpact by 5.5% in the fourth quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock valued at $360,000 after buying an additional 439 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the firm's stock in a transaction on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director owned 2,000 shares of the company's stock, valued at $87,940. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.07% of the company's stock.
Analyst Ratings Changes
A number of research analysts have weighed in on G shares. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Robert W. Baird dropped their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Mizuho lifted their target price on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Finally, Needham & Company LLC reissued a "buy" rating and set a $50.00 target price on shares of Genpact in a research report on Monday, June 30th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Genpact presently has a consensus rating of "Moderate Buy" and an average price target of $50.14.
View Our Latest Analysis on G
Genpact Stock Performance
Shares of G stock traded down $1.00 during trading hours on Friday, hitting $44.30. 1,127,913 shares of the company were exchanged, compared to its average volume of 1,420,223. Genpact Limited has a 52-week low of $32.18 and a 52-week high of $56.76. The stock has a market capitalization of $7.75 billion, a price-to-earnings ratio of 15.12, a P/E/G ratio of 1.93 and a beta of 0.94. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. The firm has a fifty day simple moving average of $43.93 and a 200 day simple moving average of $47.09.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Genpact had a net margin of 10.88% and a return on equity of 22.35%. The business's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.73 EPS. Research analysts predict that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's payout ratio is 23.21%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.